EE200300301A - Asendatud pürasinokinoksaliini derivaadid kui serotoniiniretseptorite agonistid ja antagonistid - Google Patents

Asendatud pürasinokinoksaliini derivaadid kui serotoniiniretseptorite agonistid ja antagonistid

Info

Publication number
EE200300301A
EE200300301A EEP200300301A EEP200300301A EE200300301A EE 200300301 A EE200300301 A EE 200300301A EE P200300301 A EEP200300301 A EE P200300301A EE P200300301 A EEP200300301 A EE P200300301A EE 200300301 A EE200300301 A EE 200300301A
Authority
EE
Estonia
Prior art keywords
antagonists
disorders
novel compounds
agonists
substituted
Prior art date
Application number
EEP200300301A
Other languages
English (en)
Estonian (et)
Inventor
J. Robichaud Albert
S. Mitchell Ian
Lee Taekyu
Chen Wenting
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of EE200300301A publication Critical patent/EE200300301A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200300301A 2000-12-20 2001-12-19 Asendatud pürasinokinoksaliini derivaadid kui serotoniiniretseptorite agonistid ja antagonistid EE200300301A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25676500P 2000-12-20 2000-12-20
PCT/US2001/049374 WO2002059127A2 (en) 2000-12-20 2001-12-19 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists

Publications (1)

Publication Number Publication Date
EE200300301A true EE200300301A (et) 2003-10-15

Family

ID=22973498

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300301A EE200300301A (et) 2000-12-20 2001-12-19 Asendatud pürasinokinoksaliini derivaadid kui serotoniiniretseptorite agonistid ja antagonistid

Country Status (23)

Country Link
US (1) US6638934B2 (ja)
EP (1) EP1345942B9 (ja)
JP (2) JP4346307B2 (ja)
KR (1) KR20030069192A (ja)
CN (1) CN1505631A (ja)
AT (1) ATE318819T1 (ja)
AU (1) AU2002248216B2 (ja)
BG (1) BG107864A (ja)
BR (1) BR0116347A (ja)
CA (1) CA2431970A1 (ja)
DE (1) DE60117617T2 (ja)
EE (1) EE200300301A (ja)
ES (1) ES2260335T3 (ja)
HU (1) HUP0303513A3 (ja)
IL (1) IL156201A0 (ja)
IS (1) IS6850A (ja)
MX (1) MXPA03005437A (ja)
NO (1) NO20032795L (ja)
PL (1) PL366060A1 (ja)
RU (1) RU2003121406A (ja)
SK (1) SK7022003A3 (ja)
WO (1) WO2002059127A2 (ja)
ZA (1) ZA200304303B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03005437A (es) * 2000-12-20 2003-09-10 Bristol Myers Squibb Pharma Co Derivados substituidos de pirazino quinoxalina como agonistas y antagonistas del receptor de serotonina.
US7244843B2 (en) 2003-10-07 2007-07-17 Bristol-Myers Squibb Company Modulators of serotonin receptors
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
US8685924B2 (en) 2004-08-25 2014-04-01 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
WO2007132841A1 (ja) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited 縮合複素環化合物およびその用途
WO2009063992A1 (ja) 2007-11-15 2009-05-22 Takeda Pharmaceutical Company Limited 縮合ピリジン誘導体およびその用途
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
WO2012030953A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115577A (en) 1972-06-19 1978-09-19 Endo Laboratories, Inc. Pyridopyrrolobenzheterocycles
US3914421A (en) 1972-06-19 1975-10-21 Endo Lab Pyridopyrrolobenzheterocycles for combatting depression
US4013652A (en) 1972-06-19 1977-03-22 Endo Laboratories, Inc. Pyridopyrrolobenzoxazine
US4238607A (en) 1972-06-19 1980-12-09 Endo Laboratories Inc. Pyridopyrrolo benzheterocycles
US4183936A (en) 1972-06-19 1980-01-15 Endo Laboratories, Inc. Pyridopyrrolobenzheterocycles
US4219550A (en) 1978-11-09 1980-08-26 E. I. Du Pont De Nemours And Company Cis- and trans- octahydropyridopyrrolobenzheterocycles
HUT61548A (en) * 1990-08-27 1993-01-28 Sandoz Ag Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
JP2002532504A (ja) * 1998-12-17 2002-10-02 アメリカン・ホーム・プロダクツ・コーポレイション 5−ht2c作動薬である2,3,4,4a−テトラヒドロ−1h−ピラジノ(1,2−a)キノキサリン−5(6h)−オン誘導体
MXPA03005437A (es) * 2000-12-20 2003-09-10 Bristol Myers Squibb Pharma Co Derivados substituidos de pirazino quinoxalina como agonistas y antagonistas del receptor de serotonina.

Also Published As

Publication number Publication date
WO2002059127A3 (en) 2002-10-03
KR20030069192A (ko) 2003-08-25
EP1345942B1 (en) 2006-03-01
AU2002248216B2 (en) 2007-03-01
RU2003121406A (ru) 2004-12-27
CN1505631A (zh) 2004-06-16
US6638934B2 (en) 2003-10-28
EP1345942A2 (en) 2003-09-24
NO20032795D0 (no) 2003-06-19
BR0116347A (pt) 2004-07-06
MXPA03005437A (es) 2003-09-10
EP1345942B9 (en) 2006-11-15
DE60117617D1 (de) 2006-04-27
CA2431970A1 (en) 2002-08-01
IS6850A (is) 2003-06-18
HUP0303513A3 (en) 2005-12-28
IL156201A0 (en) 2003-12-23
ZA200304303B (en) 2004-09-02
NO20032795L (no) 2003-08-04
PL366060A1 (en) 2005-01-24
JP2004524298A (ja) 2004-08-12
JP5117440B2 (ja) 2013-01-16
BG107864A (bg) 2004-03-31
WO2002059127A2 (en) 2002-08-01
JP4346307B2 (ja) 2009-10-21
SK7022003A3 (en) 2004-08-03
HUP0303513A2 (hu) 2004-01-28
JP2009215304A (ja) 2009-09-24
ES2260335T3 (es) 2006-11-01
DE60117617T2 (de) 2007-01-25
US20020177596A1 (en) 2002-11-28
ATE318819T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
EE200300303A (et) Asendatud pürrolokinoliinid ja püridokinoliinid kui serotoniini agonistid ja antagonistid
MXPA03005438A (es) Pirioindoles substituidos como agonistas y antagonistas de serotonina.
MXPA01012914A (es) Gama-carbolinas fundidas de heterociclo substituido.
ATE509929T1 (de) Substituierte tricyclische gamma-carbolineals serotonin-rezeptor-agonisten und antagonisten
HK1098460A1 (en) Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
EE200300301A (et) Asendatud pürasinokinoksaliini derivaadid kui serotoniiniretseptorite agonistid ja antagonistid
CA2354606A1 (en) Azabicycloalkane derivatives and therapeutic uses thereof
HUP0303316A2 (hu) Aril- és amino-aril-szubsztituált szerotoninreceptor agonista és antagonista ligandumok és ezeket tartalmazó gyógyszerkészítmények
GB0311349D0 (en) Therapeutic agents, compositions, preparations and uses

Legal Events

Date Code Title Description
HB1A Correction of owner name or address